Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Return on Equity (2019 - 2025)

Historic Return on Equity for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to 0.33%.

  • Volitionrx's Return on Equity fell 4200.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.33%, marking a year-over-year decrease of 4200.0%. This contributed to the annual value of 1.55% for FY2024, which is 45100.0% down from last year.
  • Latest data reveals that Volitionrx reported Return on Equity of 0.33% as of Q3 2025, which was down 4200.0% from 0.36% recorded in Q2 2025.
  • Over the past 5 years, Volitionrx's Return on Equity peaked at 6.21% during Q4 2023, and registered a low of 23.88% during Q3 2023.
  • Its 5-year average for Return on Equity is 1.45%, with a median of 0.08% in 2022.
  • As far as peak fluctuations go, Volitionrx's Return on Equity tumbled by -239700bps in 2023, and later soared by 246300bps in 2024.
  • Quarter analysis of 5 years shows Volitionrx's Return on Equity stood at 0.01% in 2021, then plummeted by -25705bps to 2.3% in 2022, then surged by 370bps to 6.21% in 2023, then tumbled by -91bps to 0.58% in 2024, then crashed by -44bps to 0.33% in 2025.
  • Its Return on Equity was 0.33% in Q3 2025, compared to 0.36% in Q2 2025 and 0.41% in Q1 2025.